Related Experiment Video
Updated: Jul 8, 2026

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene
Takanori Eguchi1, Satoshi Kubota, Kazumi Kawata
1Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Okayama City, Okayama, Japan. takigawa@md.okayama-u.ac.jp
Abstract:
Matrix metalloproteinase 3 (MMP3) is well known as a secretory endopeptidase that degrades extracellular matrices. Recent reports indicated the presence of MMPs in the nucleus (A. J. Kwon et al., FASEB J. 18:690-692, 2004); however, its function has not been well investigated. Here, we report a novel function of human nuclear MMP3 as a trans regulator of connective tissue growth factor (CCN2/CTGF). Initially, we cloned MMP3 cDNA as a DNA-binding factor for the CCN2/CTGF gene. An interaction between MMP3 and transcription enhancer dominant in chondrocytes (TRENDIC) in the CCN2/CTGF promoter was confirmed by a gel shift assay and chromatin immunoprecipitation. The CCN2/CTGF promoter was activated by overexpressed MMP3, whereas a TRENDIC mutant promoter lost the response. Also, the knocking down of MMP3 suppressed CCN2/CTGF expression. By cytochemical and histochemical analyses, MMP3 was detected in the nuclei of chondrocytic cells in culture and also in the nuclei of normal and osteoarthritic chondrocytes in vivo. The nuclear translocation of externally added recombinant MMP3 and six putative nuclear localization signals in MMP3 also were shown. Furthermore, we determined that heterochromatin protein gamma coordinately regulates CCN2/CTGF by interacting with MMP3. The involvement of this novel role of MMP3 in the development, tissue remodeling, and pathology of arthritic diseases through CCN2/CTGF regulation thus is suggested.
Insights
Matrix metalloproteinase 3 (MMP3) acts as a nuclear trans regulator of connective tissue growth factor (CCN2/CTGF). This novel function of MMP3 in chondrocytes suggests its role in tissue remodeling and arthritis.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Matrix metalloproteinase 3 (MMP3) is primarily known as an extracellular matrix-degrading enzyme.
- Recent studies suggest MMPs may function within the cell nucleus, but their roles remain largely unexplored.
Purpose of the Study:
- To investigate the novel nuclear function of human MMP3.
- To determine if MMP3 regulates the expression of connective tissue growth factor (CCN2/CTGF).
Main Methods:
- Cloning of MMP3 cDNA to identify DNA-binding factors for the CCN2/CTGF gene.
- Gel shift assays and chromatin immunoprecipitation to confirm MMP3 interaction with the CCN2/CTGF promoter.
- Overexpression and knockdown studies of MMP3, alongside cytochemical and histochemical analyses.
Main Results:
- MMP3 was identified as a DNA-binding factor that interacts with the CCN2/CTGF promoter via TRENDIC.
- Overexpression of MMP3 activated the CCN2/CTGF promoter, while MMP3 knockdown suppressed CCN2/CTGF expression.
- MMP3 was detected in the nuclei of chondrocytes both in vitro and in vivo, with evidence of nuclear translocation.
Conclusions:
- Human nuclear MMP3 functions as a trans regulator of CCN2/CTGF.
- MMP3 interacts with the CCN2/CTGF promoter and influences its transcription.
- This newly discovered role of MMP3 in regulating CCN2/CTGF suggests its involvement in chondrocyte biology, tissue remodeling, and the pathology of arthritic diseases.
Related Concept Videos
General Transcription Factors
Role of Matrix Metalloproteases in Degradation of ECM
A...
Transcription Factors
Master Transcription Regulators
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
